# Studying Different Formulations of SR13668 in Healthy Volunteers

> **NCT00896207** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 20 (actual)

## Conditions studied

- Healthy, no Evidence of Disease

## Interventions

- **DRUG:** Akt inhibitor SR13668

## Key facts

- **NCT ID:** NCT00896207
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896207, "Studying Different Formulations of SR13668 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00896207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*